Background Developmental delay may be due to a variety of factors occurring during the prenatal, perinatal, or postnatal periods, one of which is hyperbilirubinemia. Objective To evaluate the impact of hyperbilirubinemia on infant developmental delay. Methods A prospective cohort study was conducted from March to
A
Demographic Survey (Survey Demografi dan Kesehatan Indonesia), the incidence of At Dr. Sardjito Hospital, the prevalence of newborn jaundice was Hyperbilirubinemia and LBW are risk factors for developmental delay. 3 Hyperbilirubinemia in LBW treatment compared to normal infants, due to immature red blood cells, liver, and gastrointestinal system. the fourth day. Cognitive developmental delay in LBW infants is related to the level of reduced birth weight. Emotional and behavioral delays may also be present in infants with LBW. Hyperbilirubinemia complications happen if unconjugated bilirubin enters the brain, causing brain damage. The blood brain barrier is the primary protection for brain, but bilirubin may reach the blood brain barrier, leading to bilirubin encephalopathy. Bilirubin encephalopathy may be loss in surviving infants. may induce dysfunction, ranging from mild cognitive We aimed to evaluate the risk of developmental delay in low birth weight infants with and without hyperbilirubinemia, at the age of 3 months.
Methods
We performed a prospective, cohort study in the Perinatology Ward at Sanglah Hospital from March with intracranial infection, head injury, brain tumor, abnormalities. Reasons for dropping out of the study were neonatal seizure, parental refusal to join the study, or subjects moving to an unreachable address. 
Results
head circumference, body length, and albumin level, as well as other basic characteristics of subjects are shown in Table 1 . We found that hyperbilirubinemia was not a risk factor for developmental delay (Table 2) . Further analysis by multivariate logistic regression test showed that small for gestational age was significantly associated with developmental delay, but hyperbilirubinemia was not ( Table 3) .
Discussion
Studies on the effect of hyperbilirubinemia on infant development have yielded inconsistent results. Developmental delay in premature infants with hyperbilirubinemia has been reported to be higher compared to that of normal infants. The risk of gross motor delay was found to be increased in full term babies with hyperbilirubinemia. Hyperbilirubinemia was also found to be a risk factor for developmental delay at the age of 3 months, but prematurity and LBW were not.
ment when a large amount of unconjugated bilirubin in the blood passes through the blood brain barrier, then conjugates with the brain phospolipid membrane, causing neuron damage. Bilirubin also elicits especially in the auditory nerve, leading to neural hearing loss and impaired or delayed speech.
worsened the damage.
influenced by hyperbilirubinemia. However, we found that the risk for developmental delay in LBW age than in normal for gestational age infants. This result contrasts with that from a previous study perhaps due to different study design, measurement tools, and analysis. Hyperbilirubinemia was found to not be a risk factor for autism in children. infants with hyperbilirubinemia whose development effect was observed. Also, there was no correlation between peak total serum bilirubin and hearing loss. Furthermore, there was no relationship found between hyperbilirubinemia and delayed speech in premature children. Satish et al. found no significant differences for gestational age, birth weight, serum albumin, and total bilirubin between normal babies and babies with hearing loss. We also found that hyperbilirubinemia was not a risk factor for developmental delay. However, albumin bilirubin is totally bound to albumin, there would in fat could pass through the blood brain barrier by diffusion, particularly if albumin capacity to bind bilirubin and protein plasma was reduced. Therefore, albumin concentration in blood is strongly related to bilirubin in plasma.
Multivariate analysis in our study revealed a significant difference in birth weight cateegories, as the risk of developmental delay at 3 months of age was higher in small for gestational age LBW subjects. Oh et al. found that the risk of developmental delay and health complications increased for LBW babies. Bilirubin encephalopathy in LBW infants occurred at higher level bilirubin concentrations, and these infants had poor prognoses (death). Those who survived had neurological impairments, such as developmental delay and hearing loss.
A limitation of our study was that we did not measure the blood osmolality, which may influence development, such as stimulation, nutrition, environment, and prenatal factors also were not population was limited to those residing in Denpasar, and measurement of developmental delay was mia is not a risk factor for developmental delay in LBW infants, however, small gestational age with or without hyperbilirubinemia is a risk factor for developmental delay in our subjects at the age of 3 months.
Acknowledgment
his help in methodology construction and statistical analysis. 
